Advancing Science, Elevating Care
Nura Research Institute
At Nura, we help advance science by sharing our expertise and partnering on cutting-edge clinical research that improves patient outcomes and fosters innovative pain management solutions.
Clinical Studies
We are committed to advancing the field of pain management through rigorous clinical research. Our studies, published in leading medical journals, reflect our dedication to evidence-based practices and improving patient care.
Sorry, no results were found.
February 2022
Safety of Interlaminar Cervical Epidural Injections: Experience With 12,168 Procedures in a Single Pain Clinic
by David Schultz, MD in Pain Physician
December 2020
Targeted Drug Delivery for Chronic Nonmalignant Pain: Longitudinal Data From the Product Surveillance Registry
by David Schultz, MD in Neuromodulation
April 2020
Patient Satisfaction Following Intrathecal Targeted Drug Delivery for Benign Chronic Pain: Results of a Single-Center Survey Study
by David Schultz, MD in Neuromodulation
Abstracts & Articles
Our expertise is highlighted through our articles and abstracts, reflecting the depth of our knowledge and commitment to pain management. By sharing these insights, we aim to contribute to the broader medical community and enhance patient care.
Sorry, no results were found.
Filter Options
June 2024
Prevention and Treatment of Osteoporosis: Beyond the Basics
by Erin Bettendorf, MD in Minnesota Physician
July 2023
Functional Outcomes for Patients with LSS Treated with MinuteMan Minimally Invasive Fusion Monotherapy Compared to Combination Therapy with SCS in a Real-World Pain Clinic
by R. Scott Stayner, MD, PhD at ASPN
February 2023
The Importance of Multimodal Therapy: Tools for Treating Chronic Pain
by Cody Foster, MD in Minnesota Physician
February 2023
A Rare Case of Anaphylaxis to Intrathecal Fentanyl Citrate: Case Report
by Akhila Sridharamurthy, MBBS, MS at Physiatry
Current Trials
As a national leader in implantable pain management systems, Nura frequently collaborates with medical device manufacturers to study the long-term performance of specific devices.
Abbott: Spinal Cord Stimulator (SCS) and Dorsal Root Ganglion (DRG) Systems
- PROACTIVE: Prospective, Randomized, dOuble-Arm, open-label Study Assessing the Progression of SubjeCT’s ReceIVing a Neuromodulation System and the Impact on Subject OutcomEs with Remote Subject Monitoring
- REALITY: Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator: NCT03876054
Medtronic: Targeted Drug Delivery Systems and Neurostimulator Systems
Questions?
Nura is committed to ongoing clinical excellence. If you have any questions about our studies, please contact Nura at 952-937-9000 or email us at research@nuraclinics.com.
